Lung Cancer and Mesothelioma
Not eligible for ESCO credits
17.06.2010 - 18.06.2010
Golnik
COURSES AND SEMINARS
Description
Chair: T.Cufer, SI
G.L. Ceresoli, IT
AIM OF THE COURSE
The incidence of lung cancer and mesothelioma is still increasing in Central Eastern Europe, especially in younger ages and in women. With new treatment modalities patients are living longer but there is still a lack of proper palliative care measurements in many societies. In addition, methods of early detection, even though still very scarce, needs to be improved.
The course would be aimed to improve knowledge on all aspects of lung cancer and mesothelioma care among different medical specialists, thus improving multidisciplinary approach and lung cancer care in CEE region.
TARGET AUDIENCE
Practicing pulmonologists, general practitioners, medical oncologists and radiation oncologists, thoracic surgeons, and trainees in these specialties.
General information
ORGANISING SECRETARIAT
Irena Dolhar
Bolnišnica Golnik-KOPA, Golnik 36, 4204 Golnik
Slovenija/Slovenia
Tel: + 386 4 25 69 493
Fax: + 386 4 25 69 117
Email: irena.dolhar@klinika-golnik.silanguage
CONFERENCE VENUE
University Clinic of Respiratory and Allergic Diseases Golnik
Golnik 36, 4204, Golnik, Slovenia
Website: www.klinika-golnik.si
OFFICIAL LANGUAGE
The official language of the course will be English. No simultaneous translation will be provided.
CERTIFICATES
All participants will be issued with a certificate of attendance at the close of the course.
BADGE
The badge is the only official evidence of registration and should be worn at all times during the course. Loss of badge means loss of registration.
INSURANCE
The organisers bear no responsibility for untoward events in connection with, before, during and after the conference. Participants are strongly advised to take out their own personal and travel insurance coverage.
IMPORTANT DEADLINES
30/04/2010: registration deadline (after this date, registration will not be accepted)
30/04/2010: abstract submission
30/05/2010: cancellation deadline
04/06/2010: replacement deadline
Faculty list
FACULTY
G.L. Ceresoli, Istituto Humanitas Gavazzeni, Bergamo, IT
T. Cufer, University Clinic Golnik, SI
V. Gregorc, Fondazione San Raffaele, Milan, IT
I. Kern, University Clinic Golnik, SI
V. Kovac, Institute of Oncology Ljubljana, SI
U. Lunder, University Clinic Golnik, SI
P. Postmus, Free University Medical Center Amsterdam, NL
A. Rozman, University Clinic Golnik, SI
N. Schoenfeld, Helios Kliniken, Berlin, DE
T. Stupnik, University Clinical Center Ljubljana, SI
N. Triller, University Clinic Golnik, SI
P. Van Schil, University Hospital of Antwerp, Edegem, BE
E. Vrdoljak, Clinical Hospital Split, Medical School Split, HR
V. Zadnik, Institute of Oncology Ljubljana, SI
I. Zagar, Institute of Oncology Ljubljana, SI
M. Zwitter, Institute of Oncology Ljubljana, SI
LOCAL ADVISORY COMMITEE
A. Rozman, University Clinic Golnik, SI
M. Kosnik, University Clinic Golnik, SI
V. Kovac, Institute of Oncology Ljubljana, SI
M. Sok, University Medical Center Ljubljana, SI
R. Mercun, University Clinic Golnik, SI
N. Triller, University Clinic Golnik, SI
M. Zwitter, Institute of Oncology Ljubljana, SI
Programme
17 June
| 8:15 | Welcome address |
| 8:30 | Lung cancer and mesothelioma epidemiology |
| 9:00 | Role of invasive procedures in diagnostic and staging of lung cancer |
| 9:30 | Role of invasive procedures in diagnostic and staging of mesotelioma N. Schoenfeld, DE |
| 10:00 | Role of PET-CT and molecular imaging staging in therapy planning |
| 10:30 | Pathology and molecular biology of lung cancer and mesothelioma I. Kern, SI |
| 11:00 | Coffee break |
| 11:30 | Lung cancer and mesothelioma surgery P. Van Schil, BE |
| 12:00 | Systemic therapy and radiotherapy in mesothelioma G.L. Ceresoli, IT |
| 12:30 | Radiotherapy in lung cancer |
| 13:00 | Systemic therapies for lung cancer P. Postmus, NL |
14:30 | Early detection and new treatments for women at high risk S. Shanley, UK |
| 13:30 | Lunch break |
| 14:30 | Interactive clinical cases (presented by participants and discussed by experts) Discussants: N. Triller, I. Kern, P. Van Schil, G. L. Ceresoli, E. Vrdoljak, P. Postmus Moderator: T. Cufer |
| 14:30 NSCL stage IIIA and stage IV | |
| 15:30 SCLC limited and extended disease | |
| 16:30 Mesothelioma |
18 June
| 9:00 | Supportive and symptomatic care of patients on systemic therapies |
| 9:30 | Supportive and symptomatic care of patients on radiotherapy |
| 10:00 | Palliation of malignant pleural effusion A. Rozman, SI |
| 10:30 | Principles of palliative care and end of life measurements |
| 11:00 | Coffee break |
11:30 | How to improve early detection of lung cancer and mesothelioma G.L. Ceresoli, IT |
12:00 | Combined chemo-radiotherapy in lung cancer, reality or a dream |
| 12:30 | Is individualized therapy for lung cancer viable today V. Gregorc, IT |
| 13:00 | Lunch break |
| 14:00 | Minimal invasive surgery T. Stupnik, SI |
| 14:30 | How to ensure palliation of symptoms and end of life measurements at home U. Lunder, SI |
| 15:00 | Round table discussion |
| 16:00 | Adjourn |
Abstract
ABSTRACT SUBMISSION
Abstract submission deadline is 30 April 2010.
It is mandatory to submit the abstract as word file by e-mail.
The abstract should describe a clinical case relating to one of the subjects of the course (lung/mesothelioma), in the format of a clinical grand-round rather than a publication article. Some clinical cases will be selected and presented by participants.
The abstract submission form is available online.
Download: Abstract submission form_Lung Cancer and Mesothelioma_Golnik course